AGE down-regulation of monocyte RAGE expression and its association with diabetic complications in type 1 diabetes

Journal of Diabetes and its Complications

Volumn 18, Issue 1, 2004, Pages 53-59

  Miura, Junnosuke ^a   Uchigata, Yasuko ^a   Yamamoto, Yasuhiko ^b   Takeuchi, Masayoshi ^c   Sakurai, Sigeru ^b   Watanabe, Takuo ^b   Yonekura, Hideto ^b   Yamagishi, Sho Ichi ^d   Makita, Zenji ^d   Omori, Akiko ^a   Omori, Yasue ^e   Yamamoto, Hiroshi ^b   Iwamoto, Yasuhiko ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

^c HOKURIKU UNIVERSITY   (Japan)

^d KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e Eastern Japan Medical Center   (Japan)

Author keywords

Diabetic nephropathy; Diabetic retinopathy; Plasma AGE; RAGE; Type 1 diabetes

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; GLYCERALDEHYDE; LIGAND; MESSENGER RNA;

ADOLESCENT; ADULT; ARTICLE; ASSOCIATION; BINDING AFFINITY; CELL CULTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RETINOPATHY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERUM; STATISTICAL SIGNIFICANCE; VASCULAR DISEASE;

ADOLESCENT; ADULT; AGE OF ONSET; ANTIGENS, NEOPLASM; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; FEMALE; GENE EXPRESSION REGULATION; GLYCERALDEHYDE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MALE; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASES; MONOCYTES; RECEPTORS, IMMUNOLOGIC; REGRESSION ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 12144291515     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8727(02)00281-7     Document Type: Article

References (31)

1. e-carboxymethyllysine as a degradation product of fructoselysine in glycated protein. Journal of Biological Chemistry. 261:1986;4889-4894.
2. Beisswenger P.J., Makita Z., Curphey T.J., Moore L.L., Jean S., Brinck-Johnsen T., Bucala R., Vlassara H. Formation of immunochemical advanced glycosylation end products precedes and correlates with early manifestations of renal and retinal disease in diabetes. Diabetes. 44:1995;824-829.
3. Brownlee M., Cerami A., Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. New England Journal of Medicine. 318:1988;1315-1321.
4. Furuta T., Saito T., Ootaka T., Soma J., Obara K., Abe K., Yoshinaga K. The role of macrophages in diabetic glomerulosclerosis. American Journal of Kidney Diseases. 21:1993;480-485.
5. Huang J.S., Guh J.Y., Chen H.C., Hung W.C., Lai Y.H., Chuang L.Y. Role of receptor for advanced glycation end-product (RAGE) and the JAK/ STAT-signaling pathway in AGE-induced collagen production in NRK-49F cells. Journal of Cellular Biochemistry. 81:2001;102-113.
6. Ichikawa K., Yoshinari M., Iwase M., Wakisaka M., Doi Y., Iino K., Yamamoto M., Fujishima M. Advanced glycosylation end products induced tissue factor expression in human monocyte-like U937 cells and increased tissue factor expression in monocytes from diabetic patients. Atherosclerosis. 136:1998;281-287.
7. Iwashima Y., Eto M., Hata A., Kaku K., Horiuchi S., Ushikubi F., Sano H. Advanced glycation end products-induced gene expression of scavenger receptors in cultured human monocyte-derived macrophages. Biochemical and Biophysical Research Communications. 277:2000;368-380.
8. e- (Carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression. Journal of Biological Chemistry. 274:1999;31740-31749.
9. ras-dependent mitogen-activated protein kinase pathway regulated by oxidant stress. Journal of Biological Chemistry. 272:1997;17810-17814.
10. Makita Z., Radoff S., Rayfield E.J., Yang Z., Skolnik E., Delaney V., Friedman E.A., Cerami A., Vlassara H. Advanced glycosylation end products in patients with diabetic nephropathy. New England Journal of Medicine. 325:1991;836-842.
11. Mitsuhashi T., Nakayama H., Itoh T., Kuwajima S., Aoki S., Atsumi T., Koike T. Immunochemical detection of advanced glycation end products in renal cortex from STZ-induced diabetic rats. Diabetes. 42:1993;826-832.
12. Miura J., Yamagishi S., Uchigata Y., Takeuchi M., Yamamoto H., Makita Z., Iwamoto Y. Serum levels of non-carboxymethyllysine advanced glycation endproducts are correlated to severity of microvascular complications in patients with type 1 diabetes. Journal of Diabetes and Its Complications. 17:2003;16-21.
13. Nomura M., Yamagishi S., Harada S., Hayashi Y., Yamashima T., Yamashita J., Yamamoto H. Possible participation of autocrine and paracrine vascular endothelial growth factors in hypoxia-induced proliferation of endothelial cells and pericytes. Journal of Biological Chemistry. 270:1995;28316-28324.
14. Nomura T., Odagiri R., Demura R., Akashi H., Demura H. Evaluation of a new radioimmunoassay kit for urinary albumin. Journal of Medical and Pharmaceutical Science. 22:1989;213-220.
15. Schmidt A.M., Yan S.D., Brett J., Mora R., Nowygrod R., Stern D. Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products. Journal of Clinical Investigation. 91:1993;2155-2168.
16. Schroder S., Palinski W., Schmid-Schonbein G.W. Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy. American Journal of Pathology. 139:1991;81-100.
17. Suzuki H., Kurihara Y., Takeya M., Kamada N., Kataoka M., Jishage K., Ueda O., Sakaguchi H., Higashi T., Suzuki T., Takashima Y., Kawabe Y., Cynshi O., Wada Y., Honda M., Kurihara H., Aburatani H., Doi T., Matsumoto A., Azuma S., Noda T., Toyoda Y., Itakura H., Yazaki Y., Horiuchi S., Takahashi K., Kruijt J.K., van Berkel T.J.C., Steinbrecher U.P., Ishibashi S., Maeda N., Gordon S., Kodama T. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature. 386:1997;292-296.
18. Takeuchi M., Bucala R., Suzuki T., Ohkubo T., Yamazaki M., Koike T., Kameda Y., Makita Z. Neurotoxicity of advanced glycation end-products for cultured cortical neurons. Journal of Neuropathology and Experimental Neurology. 59:2000;1094-1105.
19. Takeuchi M., Makita Z., Bucala R., Suzuki T., Koike T., Kameda Y. Immunological evidence that non-carboxymethyllysine advanced glycation end-products are produced from short chain sugars and dicarbonyl compounds in vivo. Molecular Medicine. 6:2000;114-125.
20. Tanaka N., Yonekura H., Yamagishi S., Fujimori H., Yamamoto Y., Yamamoto H. The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-a through nuclear factor-κB, and by 17b-estradiol through Sp-1 in human vascular endothelial cells. Journal of Biological Chemistry. 275:2000;25781-25790.
21. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 20:1997;1183-1197.
22. Vlassara H., Brownlee M., Cerami A. High-affinity-receptor-mediated uptake and degradation of glucose-modified proteins: a potential mechanism for the removal of senescent macromolecules. Proceedings of the National Academy of Sciences of the United States of America. 82:1985;5588-5592.
23. Vlassara H., Brownlee M., Cerami A. Macrophage receptor-mediated processing and regulation of advanced glycosylation endproduct (AGE)-modified proteins: role in diabetes and aging. Progress in Clinical and Biological Research. 304:1989;205-218.
24. Yamagishi S., Hsu C.C., Taniguchi M., Harada S., Yamamoto Y., Ohsawa K., Kobayashi K., Yamamoto H. Receptor-mediated toxicity to pericytes of advanced glycosylation end products a possible mechanism of pericytes loss in diabetic microangiopathy. Biochemical and Biophysical Research Communications. 213:1995;681-687.
25. Yamagishi S., Kawakami T., Fujimori H., Yonekura H., Tanaka N., Yamamoto Y., Urayama H., Watanabe Y., Yamamoto H. Insulin stimulates the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factor. Microvascular Res. 57:1999;329-339.
26. Yamagishi S., Yonekura H., Yamamoto Y., Katsuno K., Sato F., Mita I., Ooka H., Satozawa N., Kawakami T., Nomura M., Yamamoto H. Advanced glycation end products-driven angiogenesis in vitro. Induction of the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factor. Journal of Biological Chemistry. 272:1997;8723-8730.
27. Yamamoto Y., Kato I., Doi T., Yonekura H., Ohashi S., Takeuchi M., Watanabe T., Yamagishi S., Sakurai S., Takasawa S., Okamoto H., Yamamoto H. Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice. Journal of Clinical Investigation. 108:2001;251-258.
28. Yamamoto Y., Yamagishi S., Yonekura H., Doi T., Tsuji H., Kato I., Takasawa S., Okamoto H., Abedin J., Tanaka N., Sakurai S., Unoki H., Wang H., Zenda T., Wu P.S., Segawa Y., Higashide T., Kawasaki K., Yamamoto H. Role of the AGE-RAGE system in vascular injury in diabetes. Annals of the New York Academy of Science. 902:2000;163-172.
29. Yan S.D., Schmidt A.M., Anderson G.M., Zhang J., Brett J., Zou Y.S., Pinsky D., Stern D. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. Journal of Biological Chemistry. 269:1994;9889-9897.
30. Yeh C.H., Sturgis L., Haidacher J., Zhang X.N., Sherwood S.J., Bjercke R.J., Juhasz O., Crow M.T., Tilton R.G., Denner L. Requirement of p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-κB transcriptional activation and cytokine secretion. Diabetes. 50:2001;1495-1504.
31. Young B.A., Johnson R.J., Alpers C.E., Eng E., Gordon K., Floege J., Couser W.G., Seidel K. Cellular events in the evolution of experimental diabetic nephropathy. Kidney International. 47:1995;935-944.